- Home
- INMB vs ATCH Comparison
INMB vs ATCH Comparison
Compare INMB & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INMB | ATCH |
|---|---|---|
| Founded | 2015 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.4M | 40.1M |
| IPO Year | 2018 | 2024 |
Fundamental Metrics
Financial Performance| Metric | INMB | ATCH |
|---|---|---|
| Price | $1.59 | $0.22 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $5.40 | $1.00 |
| AVG Volume (30 Days) | 364.9K | ★ 3.0M |
| Earning Date | 05-07-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 11.85 | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | ★ $50,000.00 | N/A |
| Revenue This Year | N/A | $84.47 |
| Revenue Next Year | N/A | $39.32 |
| P/E Ratio | ★ N/A | $4.70 |
| Revenue Growth | ★ 257.14 | N/A |
| 52 Week Low | $1.09 | $0.14 |
| 52 Week High | $11.64 | $1.92 |
Technical Indicators
Market Signals| Indicator | INMB | ATCH |
|---|---|---|
| Relative Strength Index (RSI) | 57.51 | 35.18 |
| Support Level | $1.38 | $0.21 |
| Resistance Level | $1.71 | $0.24 |
| Average True Range (ATR) | 0.11 | 0.02 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 54.17 | 2.28 |
Price Performance
Historical ComparisonAbout INMB INmune Bio Inc.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.
About ATCH AtlasClear Holdings Inc.
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.